In Silico Analysis of the Correlation of KIF2C with Prognosis and Immune Infiltration in Glioma

Figure 7

Higher expression of KIF2C was correlated with shorter survival time in glioma. (a, b) Higher expression of KIF2C correlated to shorter survival time in both primary and recurrent gliomas. (c, d) The correlation between KIF2C expression and survival time in primary and recurrent grade II gliomas. (e, f) The correlation between KIF2C expression and survival time in primary and recurrent grade III gliomas. (g, h) The correlation between KIF2C expression and survival time in primary and recurrent grade IV gliomas.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)